Setting the bases for synthetic biology in Europe

Synthetic biology has emerged as a very recent but highly promising approach to re-organizing the scientific biological endeavor by integrating central elements of engineering design. By applying the tool box of engineering disciplines such as electrical, mechanical, or chemical engineering and computer sciences, including the vigorous application of modeling techniques and organizing the development of novel biological systems along a hierarchical systems architecture with defined and standardized interfaces, synthetic biology aims at no less than revolutionizing the way we do bioengineering today. If successful, synthetic biology will transform bioengineering into a highly successful and sustainable life science industry.The objective of this coordination action (CA) EMERGENCE is to provide a communication and working platform for the emerging European synthetic biology community in order to strengthen the organizational and conceptual basis of the synthetic biology as a true engineering discipline in biological engineering.


Federal Institute of Technology (ETH Zurich), Sven Panke, Jörg Stelling, Frauke Greve

Consejo Superior de Investigaciones Scientificas (CSIC), Victor de Lorenzo

Spanish National Cancer Research Centre (CNIO), Alfonso Valencia

Helmholtz Zentrum für Infektionsforschung, (HZI), Vitor Martins dos Santos

Royal DSM, Luis Pasamontes

University College London (UCL), Nicolas Szita

Geneart AG, Ralf Wagner, Marcus Graf

Center for Genomic Regulation (CRG), Luis Serrano

University of Cambridge (UCAM), Jim Haseloff

Ecole Polytechnique (EP), Alfonso Jaramillo

Massachusetts Institute of Technology (MIT), Randy Rettberg


Vitor Martins dos Santos


ETH Zürich (CH)



Funding Agency